A Comparison of Chemoembolization Endpoints Using Angiographic versus Transcatheter Intraarterial Perfusion/MR Imaging Monitoring

Journal of Vascular and Interventional Radiology

Volumn 18, Issue 10, 2007, Pages 1249-1257

  Lewandowski, Robert J ^a   Wang, Dingxin ^a,b   Gehl, James ^a   Atassi, Bassel ^a   Ryu, Robert K ^a   Sato, Kent ^a   Nemcek Jr , Albert A ^a   Miller, Frank H ^a   Mulcahy, Mary F ^a   Kulik, Laura ^a   Larson, Andrew C ^a,b   Salem, Riad ^a   Omary, Reed A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; MITOMYCIN C;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BIOASSAY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERFUSION; PRIORITY JOURNAL; REPRODUCIBILITY; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER CIRCULATION; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 34548824812     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2007.06.028     Document Type: Article

References (36)

1. Marcos-Alvarez A., Jenkins R.L., Washburn W.K., et al. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg 131 (1996) 292-298
2. Bramhall S.R., Gur U., Coldham C., et al. Liver resection for colorectal metastases. Ann R Coll Surg Engl 85 (2003) 334-339
3. Okada S., Okazaki N., Nose H., Yoshimari M., and Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 16 (1992) 112-117
4. Colleoni M., Bajetta E., Nelli P., et al. Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: the experience of the National Cancer Institute of Milan. Ann Oncol 4 (1993) 489-493
5. Boucher E., Corbinais S., Brissot P., Boudjema K., and Raoul J.L. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen). Cancer Chemother Pharmacol 50 (2002) 305-308
6. Llovet J.M., Sala M., Castells L., et al. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology 31 (2000) 54-58
7. Chow P.K., Tai B.C., Tan C.K., et al. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: a multicenter randomized controlled trial. Hepatology 36 (2002) 1221-1226
8. Lai C.L., Wu P.C., Chan G.C., Lok A.S., and Lin H.J. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma: a prospective randomized trial. Cancer 62 (1988) 479-483
9. Mulcahy M.F. Management of hepatocellular cancer. Curr Treat Options Oncol 6 (2005) 423-435
10. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
11. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
12. Mavligit G.M., Charnsangavej C., Carrasco C.H., et al. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 260 (1988) 974-976
13. Tellez C., Benson III A.B., Lyster M.T., et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82 (1998) 1250-1259
14. Soulen M.C. Chemoembolization of hepatic malignancies. Oncology (Williston Park) 8 (1994) 77-84
15. Salman H.S., Cynamon J., Jagust M., et al. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2 (2002) 173-179
16. Therasse E., Breittmayer F., Roche A., et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 189 (1993) 541-547
17. Stokes K.R., Stuart K., and Clouse M.E. Hepatic arterial chemoembolization for metastatic endocrine tumors. J Vasc Interv Radiol 4 (1993) 341-345
18. Gupta S., Yao J.C., Ahrar K., et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J 9 (2003) 261-267
19. Giroux M.F., Baum R.A., and Soulen M.C. Chemoembolization of liver metastasis from breast carcinoma. J Vasc Interv Radiol 15 (2004) 289-291
20. Rajan D.K., Soulen M.C., Clark T.W., et al. Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization. J Vasc Interv Radiol 12 (2001) 187-193
21. Brown D.B., Geschwind J.F., Soulen M.C., Millward S.F., and Sacks D. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 17 (2006) 217-223
22. Geschwind J.F., Ramsey D.E., van der Wal B.C., et al. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol 26 (2003) 111-117
23. Larson A WD, Atassi B, Sato K, et al. Transcatheter intraarterial first-pass perfusion (TRIP)-MRI monitoring of chemoembolization for hepatocellular carcinoma. Radiology 2007 (in press).
24. Brown D.B., Cardella J.F., Sacks D., et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 17 (2006) 225-232
25. Georgiades C.S., Hong K., D'Angelo M., and Geschwind J.F. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16 (2005) 1653-1659
26. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
27. Soresi M., Magliarisi C., Campagna P., et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res 23 (2003) 1747-1753
28. Materne R., Smith A.M., Peeters F., et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 47 (2002) 135-142
29. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
30. Brown D.B., Pilgram T.K., Darcy M.D., et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 16 (2005) 1661-1666
31. Hong K., Kobeiter H., Georgiades C.S., Torbenson M.S., and Geschwind J.F. Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer. J Vasc Interv Radiol 16 (2005) 1711-1717
32. Kobayashi N., Ishii M., Ueno Y., et al. Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver 19 (1999) 25-31
33. Xiong Z.P., Yang S.R., Liang Z.Y., et al. Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 3 (2004) 386-390
34. Rhee T.K., Young J.Y., Larson A.C., et al. Effect of transcatheter arterial embolization on levels of hypoxia inducible factor-1 alpha in rabbit VX2 liver tumors. J Vasc Interv Radiol 18 (2007) 639-645
35. Gwak G.Y., Yoon J.H., Kim K.M., et al. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol 42 (2005) 358-364
36. Vali M., Liapi E., Kowalski J., et al. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer. J Vasc Interv Radiol 18 (2007) 95-101